News

Groq and HUMAIN Unveil OpenAI's Latest Models on GroqCloud

Groq and HUMAIN Unveil OpenAI's Latest Models on GroqCloud

Groq and HUMAIN Collaborate to Launch OpenAI's New Models

Available worldwide with real-time performance, low cost, and local support.

Groq, a leader in the field of fast AI inference, has partnered with HUMAIN to announce the immediate availability of OpenAI's two innovative models designed for developers. The models gpt-oss-120B and gpt-oss-20B deliver impressive performance with full 128K context, allowing for real-time responses and integrated server-side tools right from their inception.

This launch signifies a milestone in Groq's ongoing commitment to support OpenAI’s development journey. This partnership is set to enable global access to these powerful models, ensuring local availability through HUMAIN's infrastructure.

“OpenAI is raising the bar for open-source models,” remarked Jonathan Ross, CEO of Groq. “Our technology is crafted to facilitate the use of such models at remarkable speeds and cost-efficiency from day one. By collaborating with HUMAIN, we significantly enhance support for developers in the region, allowing them to innovate more effectively.”

In agreement, HUMAIN's CEO, Tareq Amin, stated, “With Groq’s extraordinary inference speed and cost-effectiveness, we are equipped to bring cutting-edge AI solutions to our region. Together, we're ushering in a new era of innovation in Saudi Arabia by leveraging optimal open-source models alongside scalable infrastructure.”

Maximizing the Potential of OpenAI's New Models

Full model capabilities deliver optimal results

To fully leverage OpenAI's latest models, Groq has incorporated extensive context and advanced tools such as code execution and web search capabilities. These features assist developers in conducting real-time information retrieval, facilitating complex workflows through robust reasoning.

Unbeatable Price-Performance Ratio

Groq's specialized technology stack is designed to provide the most competitive pricing for OpenAI’s latest models, ensuring that developers enjoy both speed and precision without breaking the bank.

The gpt-oss-120B model currently operates at speeds exceeding 500 transactions per second (t/s), while the gpt-oss-20B model achieves over 1000 t/s on GroqCloud.

Competitive Pricing Details

Groq is pleased to offer OpenAI's new models at the following rates:

  • gpt-oss-120B: $0.15 per M input tokens and $0.75 per M output tokens
  • gpt-oss-20B: $0.10 per M input tokens and $0.50 per M output tokens

As a limited-time offer, there will be no charges for tool calls used with OpenAI's open models.

A Global Reach from Day Zero

With a strong global presence, Groq ensures reliable and high-performance AI inference across diverse geographies, including North America, Europe, and the Middle East. Through GroqCloud, OpenAI's models are now universally accessible with minimal latency, empowering developers worldwide.

About Groq

Groq stands at the forefront of redefining the AI inference landscape, offering unparalleled price-performance. Its proprietary processing units and cloud infrastructure are meticulously engineered to execute powerful models instantaneously and cost-effectively. Trust from over 1.9 million developers speaks volumes about Groq's credibility and efficacy.

Contact: For inquiries, please reach out to us through our website.

About HUMAIN

HUMAIN, a prominent AI company funded by the public investment fund (PIF), specializes in full-stack AI services across critical areas including advanced AI models, next-gen data centers, and transformative AI solutions. By empowering organizations of all types, HUMAIN unlocks immense value and nurtures extensive AI capabilities, ensuring a competitive advantage in the global market.

Frequently Asked Questions

What models are Groq and HUMAIN launching together?

They are launching OpenAI's gpt-oss-120B and gpt-oss-20B models, providing real-time performance and local support.

How does Groq ensure low costs for these models?

Groq utilizes a specialized technology stack designed to deliver the best price-performance ratio while maintaining speed and accuracy.

Where can developers access these models?

Developers can access these models through GroqCloud, which is available globally.

What unique features do the new OpenAI models offer?

The models feature a full 128K context length and integrated tools for code execution and web search, enhancing real-time data use.

Who benefits from this partnership between Groq and HUMAIN?

This partnership primarily benefits developers in need of advanced AI tools, particularly in regions like Saudi Arabia, by providing innovative, efficient solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading